Successful Scale-up and Facility Expansion for Genomic Medicine

December 1, 2022 from 09:30 to 16:30
Biotech Training Facility

As genomic medicines move towards commercialization, a robust, scalable and affordable manufacturing process is critical to ensure these novel therapies reach the patient and that a pipeline of clinical assets can be rapidly developed.

This seminar given by our partner Pall, will address the current manufacturing challenges faced by the industry and offer potential solutions. Choosing the right technologies capable of producing the required amount of virus or mRNA at the right quality is more important than ever.

Pall’s automated, end-to-end integrated platform solution coupled with our AcceleratorSM process development services (PDS) offers a holistic approach designed to decease risk, reduce costs and help speed you to market for your viral vector or mRNA manufacturing.

More information and registration

Did you know? Leiden University offers free online courses on subjects such as clinical kidney